This study is looking at how continuous glucose monitoring (CGM) helps people with type 2 or steroid-induced diabetes manage their blood sugar after leaving the hospital. You might be able to join if you are an adult, 18 or older, treated in the hospital for these types of diabetes, and will be using insulin after discharge. The study is comparing two groups: one will use the Libre 3 Plus continuous glucose monitoring (CGM) system, and the other will use a blinded CGM and check blood sugar with finger sticks. The main goal is to see how much time participants spend with their blood sugar in a healthy range (70-180 mg/dl) about 20-30 days after discharge. The study aims to enroll 64 people, but its current status is unclear.

Study design

This is a randomized controlled trial, meaning participants are randomly assigned to one of two groups. It plans to include 64 participants.

What's involved

You would wear a continuous glucose monitor for 28 days after leaving the hospital and participate in telehealth diabetes management visits. Your total time in the study would be up to 35 days.

Compensation

Not stated in the trial record.

Follow-up

Your blood sugar levels will be measured about 20-30 days after discharge to see how well the treatment is working.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.